article thumbnail

Protecting the Consumer at the Heart of DTC Precision Medicine

Bill Of Health

The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.

article thumbnail

From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

Bill Of Health

The EU’s AI Act sets rigorous standards for high-risk AI systems, emphasizing robust data quality, detailed record-keeping, and clear user information to ensure transparency and accountability. These reforms streamline liability claims and establish clearer accountability for AI-generated issues.